As GM-CSFR is mostly expressed on myeloid cells such as DC, monocytes and macrophages, the anti-cancer GM-CSF effects are largely attributed to the influx and activation of DC and pro-inflammatory M1 macrophages, which subsequently activate T cells through antigen presenting in the tumor tissue [34]. This evidence concerns the gene CSF2 and cancer.